Journal of Virology, October 1998, p. 7807-7814, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461
Received 12 May 1998/Accepted 24 June 1998
| |
ABSTRACT |
|---|
|
|
|---|
In addition to their role in reverse transcription, the R-region sequences of some retroviruses affect viral transcription. The first 28 nucleotides of the R region within the long terminal repeat (LTR) of the murine type C retrovirus SL3 were predicted to form a stem-loop structure. We tested whether this structure affected the transcriptional activity of the viral LTR. Mutations that altered either side of the stem and thus disrupted base pairing were generated. These decreased the level of expression of a reporter gene under the control of viral LTR sequences about 5-fold in transient expression assays and 10-fold in cells stably transformed with the LTR-reporter plasmids. We also generated a compensatory mutant in which both the ascending and descending sides of the stem were mutated such that the nucleotide sequence was different but the predicted secondary structure was maintained. Most of the activity of the wild-type SL3 element was restored in this mutant. Thus, the stem-loop structure was important for the maximum activity of the SL3 LTR. Primer extension analysis indicated that the stem-loop structure affected the levels of cytoplasmic RNA. Nuclear run-on assays indicated that deletion of the R region had a small effect on transcriptional initiation and no effect on RNA polymerase processivity. Thus, the main effect of the R-region element was on one or more steps that occurred after the template was transcribed by RNA polymerase. This finding implied that the main function of the R-region element involved RNA processing. R-region sequences of human immunodeficiency virus type 1 or mouse mammary tumor virus could not replace the SL3 element. R-region sequences from an avian reticuloendotheliosis virus partially substituted for the SL3 sequences. R-region sequences from Moloney murine leukemia virus or feline leukemia virus did function in place of the SL3 element. Thus, the R region element appears to be a general feature of the mammalian type C genus of retroviruses.
| |
INTRODUCTION |
|---|
|
|
|---|
R regions are sequences within the long terminal repeats (LTRs) of retroviruses that are present at both the 5' and 3' ends of the primary viral transcript. They play an essential role in viral replication. Specifically, they are critical for the first polymerase jump during reverse transcription of the viral genomic RNA into DNA (26). In addition to the role in reverse transcription, LTR R regions are also important for transcriptional activity of a variety of retroviruses. The best-studied example is the transactivation response (TAR) element within the R regions of human and simian immunodeficiency viruses (HIVs and SIVs) (6, 41). R-region sequences also affect transcription of other retroviruses, including human T-cell leukemia virus type 1 (HTLV-1), bovine leukemia virus, the reticuloendotheliosis virus (REV) group member chicken syncytial virus (CSV), murine leukemia viruses (MuLVs), and mouse mammary tumor virus (MMTV) (13, 14, 17, 19, 20, 23, 30, 35, 39, 40). In all of these cases, deletion of R-region sequences resulted in decreased expression of a reporter gene under control of the corresponding viral LTR. Many of these viruses do not encode any transactivator proteins themselves, and the effects are presumably mediated by cellular factors that recognize the viral sequences. For HTLV-1 and bovine leukemia virus, the effects of the R region also appear to be independent of the virally encoded transactivator proteins (14, 20, 35).
Studies on the mechanisms by which sequences within the R regions of various retroviruses act indicated that these sequences can affect various steps in the production of viral RNA. In the cases of HIV and SIV, transcribed TAR sequences form a stem-loop structure at the 5' ends of the lentivirus RNAs (6). Virally encoded Tat protein binds to the TAR element in the nascent RNA (12, 43, 45). Tat-TAR interaction facilitates transcription by affecting both initiation and polymerase processivity (7, 11, 21, 24, 25, 28, 29, 44, 50, 52, 54). In the cases of the MuLVs SL3 and Akv, deletion of the first 28 nucleotides of the R region affected the steady-state levels of cytoplasmic RNA (13). This was due to effects on both transcriptional initiation and some postinitiation step during RNA polymerization or processing (13). Studies with MMTV showed that mutations within the short, 15-bp R region of this virus decreased the level of transcription initiation (39). Thus, the R regions of different retroviruses can act by distinct mechanisms involving transcriptional initiation and/or postinitiation steps.
As is the case with the TAR elements of HIV and SIV, stem-loop
structures presumably form within RNA transcribed from the R regions of
other viruses, and these might be important for the effects of these
sequences. The first 35 nucleotides of the CSV R region were predicted
to be capable of folding into a secondary structure of
G =
24.7 kcal/mol (40). A stem-loop structure was also
suggested to form within the crucial 5' 28 nucleotides of the R region
of SL3 and Akv (13). Although the
G of this stem-loop was estimated to be only
7.5 kcal/mol, its existence was
supported by the observation that the nucleotides predicted to be
involved in base pairing were precisely conserved among all MuLVs,
feline leukemia virus (FeLV), and type C primate viruses (13).
This study was undertaken to address whether the predicted secondary structure was important for activity of the MuLV R region. We also tested whether the MuLV R region functioned analogously to the TAR element of HIV in affecting the processivity of RNA polymerase. In addition, we examined whether the LTR R sequences from other retroviruses could substitute for the MuLV R region in driving the expression of a reporter gene.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell lines. NIH 3T3 cells were maintained in Dulbecco's modified Eagle medium with 10% bovine serum. K562 cells were maintained in RPMI 1640 with 10% fetal bovine serum. Media were supplemented with 100 U of penicillin and 100 µg of streptomycin per ml.
Plasmids. The SL3 and SL3 R-region deletion plasmids (Fig. 1) were previously described (13). We previously showed that the R region affected activity of LTR-reporter plasmids whether only part of the R region or a 400-nucleotide segment containing R, U5, and most of the 5' untranslated sequence was present in the plasmids (13). The SL3-CAT (chloramphenicol acetyltransferase) plasmid containing only part of the R region was used in this study because the presence of convenient BssHII and HindIII restriction sites (Fig. 1C) facilitated the construction of the various plasmids. To generate each mutant, the BssHII-to-HindIII fragment of SL3-CAT was replaced with a fragment containing the appropriate mutation. To generate these fragments, complementary oligonucleotides containing the mutations were synthesized. The oligonucleotides were designed such that they contained BssHII and HindIII cohesive ends after the two strands were hybridized. The double-stranded fragments were inserted into the corresponding sites of SL3-CAT. The successful construction of each plasmid was confirmed by sequencing. The R-region sequences of heterologous retroviruses were inserted into the SL3 LTR by a similar strategy using synthetic oligonucleotides. HIV-1 CAT and simian virus 40 Tat plasmids were described by Rosen et al. (41, 42).
|
CAT assays. Transient transfections and CAT assays were performed as previously described (13, 31, 34, 37, 53). Acetylation of chloramphenicol was quantified by PhosphorImager analysis. Data are presented as means of multiple trials.
Stable transformation of NIH 3T3 fibroblasts. NIH 3T3 fibroblasts were transformed with 18 µg of LTR-CAT plasmid and 2 µg of pSV2neo as previously described (13). To minimize the effects of integration sites on LTR activity, G418-resistant clones were grown as pools. To minimize the possibility of single clones overgrowing the pools, they were used as soon as sufficient numbers of cells were obtained.
CAT assays, primer extension analysis, and nuclear run-on assays
with stably transformed cells.
CAT assays and primer extension
analysis were performed as previously described (13).
Nuclear run-on assays were performed as previously described
(13), with the following changes. Before ethanol
precipitation, the radiolabeled RNA was briefly fragmented by
incubation in 0.2 M NaOH at 0°C for 10 min as described by Laspia et
al. (25). Samples were neutralized by the addition of 1 M
HEPES-KOH (pH 7.5) to a final concentration of 0.25 M and then ethanol
precipitated. CAT and
-actin DNA probes were single-stranded fragments cloned in an M13 bacteriophage vector (25). The 5' and 3' probes were fragments II and V, respectively, of Laspia et al.
(25).
| |
RESULTS |
|---|
|
|
|---|
Secondary structure is important for the activity of the MuLV R region. To test whether secondary structure is important for the activity of the R region, mutations were introduced into the 5' end of the R region of the LTR of the MuLV SL3. The first 28 nucleotides of the 68-nucleotide-long R region of SL3 were predicted to form the stem-loop structure shown in Fig. 1A (13). The existence of this stem-loop was supported by the conservation of the nucleotides involved in base pairing among MuLVs and related retroviruses of cats and primates (13). With the exception of two nucleotides in the loop, the nucleotides that were implicated in base pairing are the only ones that are conserved among these viruses (13). Sixteen nucleotides were predicted to base pair to form the stem, and eight nucleotides were predicted to be present in the loop (Fig. 1A). On the descending side of the stem, three nucleotides were predicted to form a bulge. It is unclear whether the G in the middle of the bulge would base pair with the single C in the bulge that is present on the ascending side of the stem (Fig. 1A). Double-stranded oligonucleotides containing mutations in various parts of this predicted structure (Fig. 1B) were synthesized and substituted into a plasmid containing the SL3 LTR linked to the CAT reporter gene (Fig. 1C).
One mutation, S
R, was a deletion of 28 nucleotides of the R region,
from positions +4 to +31, inclusive (Fig. 1B). This deletion encompassed most of the stem-loop structure. As previously described (13), this mutation reduced LTR activity about 10-fold
compared to wild-type SL3 in transient transfection assays (Fig.
2), thus confirming the importance of
this portion of the R region.
|
R mutation decreased LTR activity to
about 4% of that of the intact LTR sequences (Fig. 3). Mutations that
disrupted secondary structure of the R region also had a greater effect when stably transformed cells were used compared to what was observed in transient expression assays (Fig. 3). Mutation of either the ascending or descending side of the stem inhibited LTR activity to
about 1/10 of the level of the intact LTR. Restoration of the secondary
structure in the compensatory mutant again restored activity to about
half of that of the intact LTR (Fig. 3). The activity of the
compensatory mutation was roughly five times as high as that of either
of the mutations that disrupted base pairing. This finding confirmed
the importance of secondary structure for the activity of the R region
and showed that it is important in templates that are integrated into
the host cell genome.
|
R mutant and
165-nucleotide products from the ASC, DES, and COMP mutants (Fig.
4). Thus, the secondary structure
mutations did not alter the initiation site of transcription. The
mutations did reduce the steady-state levels of cytoplasmic RNA (Fig.
4) to an extent similar to the reductions seen in the CAT assays (Fig.
3). The compensatory mutation restored the level of cytoplasmic RNA to
about half of the level of the intact LTR (Fig. 4). Thus, the secondary
structure of the R region was important for one or more processes that
affected the steady-state levels of LTR-driven, cytoplasmic
transcripts.
|
SL3 R-region sequences function differently from the HIV TAR
element.
Secondary structure is important for activity of both the
SL3 R region and the HIV TAR element, and each element is positioned similarly in the viral LTRs. Therefore, we considered the possibility that the MuLV sequences function equivalently to HIV TAR. Binding of
Tat to TAR RNA results in increased processivity of RNA polymerase II
(7, 11, 21, 24, 25, 28, 29, 44, 50, 52, 54). To test whether
a cellular factor might recognize the SL3 R-region sequences and affect
processivity of RNA polymerase II, nuclei were prepared from the cells
that were stably transformed with the SL3- and S
R-CAT plasmids.
Nuclear run-on assays were performed with probes from the 5' and 3'
portions of the CAT genes as described by Laspia et al.
(25). Deletion of the R region reduced the level of LTR-CAT
transcripts produced to about 40% of the level of the intact LTR
whether the probe used was from the 5' or the 3' end of the CAT gene
(Fig. 5). Thus, deletion of the R region
did not affect the fraction of transcripts that proceed from the 5' to
the 3' part of the CAT template. Therefore, the SL3 R region had no
effect on RNA polymerase II processivity.
|
R). The chimeric LTRs
were tested in both human and mouse cells. The presence of the SL3 R
region did not increase activity of the HIV-1 U3 (Fig. 6B) but did
affect the activity of the SL3 LTR in parallel controls (Fig. 6B). As a
control for the function of the HIV-1 LTR, cotransfection of a Tat
expression plasmid was shown to stimulate its activity about 75-fold in
human Jurkat cells (Fig. 6B). As reported by others (2, 15, 16,
32, 33, 47, 50), Tat was not active on the intact TAR element in
mouse cells. We conclude that the MuLV R region cannot functionally
substitute for the HIV TAR element. Thus, the MuLV and HIV-1 elements
function by different mechanisms.
|
R-region sequences of other type C retroviruses can substitute for the SL3 element. R regions of other retroviruses were reported to affect LTR activity (39, 40). We tested whether several of these could functionally substitute for the SL3 element. LTR-CAT plasmids containing the heterologous sequences (Fig. 7A) were constructed and tested in transient expression assays.
|
R. In the murine fibroblast line NIH
3T3, the CSV sequences restored part of the activity (Fig. 7B). This
finding suggests that the CSV and SL3 elements may function by similar
mechanisms at least in this one cell line.
| |
DISCUSSION |
|---|
|
|
|---|
The existence of a stem-loop structure at the 5' end of the R region of MuLVs and related feline and primate retroviruses was predicted based on evolutionary conservation of the nucleotides that base pair to form the structure. The mutagenesis studies presented here strongly support the argument that this structure is necessary for maximum activity of the SL3 LTR. Mutation of nucleotides involved in base pairing inhibited the activity of the R region. A compensatory mutation that formed the same predicted secondary structure but not the actual sequence restored most of the activity of the element. The equivalent sequences from Mo-MuLV and FeLV were able to substitute, at least partially, for the SL3 element. These results are consistent with the hypothesis that a similar element is a general feature of members of the mammalian type C genus (49) of retroviruses.
Previous results suggested that the SL3 R-region element functions at two steps, initiation of transcription and a postinitiation step (13). The data presented here partially clarify the molecular mechanisms involved. Nuclear run-on assays indicated that the R-region element affected the loading of RNA polymerase onto the 5' portion of the CAT template. However, the R region had no effect on whether the polymerase proceeded to the 3' end of the template. We interpret these observations to mean that the R element has some effect on transcriptional initiation but no effect on polymerase processivity. Thus, the SL3 R region functions differently from the HIV Tat-TAR system. The quantitative effect of deletion of the R region in nuclear run-on assays was a decline of 2.5- to 3.5-fold (Fig. 5 and reference ;[13]). This accounts for only a minor fraction of the roughly 20-fold effect of deletion of the R region seen in primer extension analysis and reporter gene expression assays. Therefore, the main effect is on one or more steps that occur after the template is transcribed by RNA polymerase. This implies that the main function of the R-region element involves one or more steps in RNA processing.
We propose that the stem-loop structure of the first 28 nucleotides of the R region exists at the 5' end of the LTR-driven transcripts. The nucleotide substitutions that reduced activity of the element were those that altered base pairing in the stem. None of the mutations that altered the loop had substantial effects on activity. Additional evidence that the sequence of the loop was not important was provided by the observation that the loop sequence varied among mammalian type C retroviruses (13). However, we did not test whether removal of the loop structure affected activity. Removal of the bulge in the stem had no effect on activity. On the other hand, the MMTV R/SL3 U5 construct had little activity. This mutant was predicted to have three differences in the bulge or the loop plus an altered base pair between nucleotides 3 and 26. Most likely, this base pair is crucial for activity.
The 15-bp MMTV R region was shown to contain an element that stimulates transcription in cells and in nuclear extracts (39). However, this element could not substitute for the SL3 element even though the two sequences are identical at 11 of 15 positions (Fig. 7). Most likely, this is because the SL3 element acts primarily on RNA processing whereas the MMTV element affects transcriptional initiation. However, the SL3 sequences do appear to have a modest effect on RNA polymerase loading in run-on assays and thus presumably on transcriptional initiation. Perhaps the MMTV R-region binding factor has no activity in the context of the SL3 U3 promoter and enhancer elements.
The 5' ends of HIV-1 LTR-driven transcripts are folded into a well-characterized hairpin structure. These sequences did not efficiently substitute for the SL3 element. Thus, not all stem-loop structures can perform the function of the SL3 element. One obvious way in which the SL3 element differs from the HIV-1 structure is that the stem of the SL3 element is much shorter, with fewer base pairs to stabilize it. Curiously, the CSV sequence, which was also predicted to fold into a stem-loop structure (40), did give some activity in NIH 3T3 fibroblasts. It may be simply fortuitous that the CSV and SL3 elements fold into sufficiently similar structures that the CSV element can partially substitute for the SL3 element. However, it is also conceivable that the SL3 and CSV elements perform similar functions. The taxonomical position of the REV group within the Retroviridae is uncertain (10, 51). However, there is evidence that the REVs are related to mammalian retroviruses, all of which use tRNAPro to initiate reverse transcription (38). The capsid and reverse transcriptase proteins share antigenic similarity (1, 3-5, 8, 18, 36). The REV env-encoded proteins show sequence similarity with both the baboon endogenous virus and type D simian retroviruses (48). Spleen necrosis virus, a member of the REV group, shares a cellular receptor with type D simian retroviruses (22). MuLVs and REV may share a translational regulatory element (27). The ability of the CSV 5' end to substitute partially for the SL3 element may be an additional hint of similarity between these groups of retroviruses.
In summary, a small stem-loop structure of modest stability is important for the maximum expression of SL3 LTR-driven transcripts. The element appears to function mainly at a posttranscriptional step and presumably exists at the 5' end of LTR-driven transcripts. Other mammalian type C viruses appear to have similar elements.
| |
ACKNOWLEDGMENTS |
|---|
We thank Michael Laspia for providing the 5' and 3' CAT gene probes.
This work was supported by NIH grants CA44822 and CA57337 to J.L. Core facilities for oligonucleotide synthesis, PhosphorImager analysis, and DNA sequencing were supported by NIH Cancer Center grant CA13330 and NIH Center for AIDS Research grant AI27741 to the Albert Einstein College of Medicine. A.T. was supported by NIH training grant GM7288.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Genetics, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-3715. Fax: (718) 430-8778. E-mail: lenz{at}aecom.yu.edu.
Present address: Hoffmann-La Roche Inc., Nutley, NJ 07110.
Present address: Regeneron Pharmaceuticals, Tarrytown, NY 10591.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Allen, P. T., J. E. Strickland, A. K. Fowler, and M. R. Waite. 1980. Antigenic determinants shared by the DNA polymerases of reticuloendotheliosis virus and mammalian type C retroviruses. Virology 105:273-277[Medline]. |
| 2. |
Alonso, A.,
T. P. Cujec, and B. M. Peterlin.
1994.
Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.
J. Virol.
68:6505-6513 |
| 3. |
Barbacid, M.,
M. D. Daniel, and S. A. Aaronson.
1980.
Immunological relationships of OMC-1, an endogenous virus of owl monkeys, with mammalian and avian type C viruses.
J. Virol.
33:561-566 |
| 4. |
Barbacid, M.,
E. Hunter, and S. A. Aaronson.
1979.
Avian reticuloendotheliosis viruses: evolutionary linkage with mammalian type C retroviruses.
J. Virol.
30:508-514 |
| 5. |
Bauer, G., and H. M. Temin.
1980.
Specific antigenic relationships between the RNA-dependent DNA polymerases of avian reticuloendotheliosis viruses and mammalian type C retroviruses.
J. Virol.
34:168-177 |
| 6. |
Berkhout, B.
1992.
Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis.
Nucleic Acids Res.
20:27-31 |
| 7. | Berkhout, B., R. H. Silverman, and K. Jeang. 1989. Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282[Medline]. |
| 8. |
Charman, H. P.,
R. V. Gilden, and S. Oroszlan.
1979.
Reticuloendotheliosis virus: detection of immunological relationship to mammalian type C retroviruses.
J. Virol.
29:1221-1225 |
| 9. |
Chatis, P. A.,
C. A. Holland,
J. E. Silver,
T. N. Frederickson,
N. Hopkins, and J. W. Hartley.
1984.
A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
J. Virol.
52:248-254 |
| 10. | Coffin, J. M., S. E. Hughes, and H. E. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 11. |
Cujec, T. P.,
H. Okamoto,
K. Fujinaga,
J. Meyer,
H. Chamberlin,
D. O. Morgan, and B. M. Peterlin.
1997.
The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.
Genes Dev.
11:2645-2657 |
| 12. | Cullen, B. R. 1990. The HIV-1 tat protein: an RNA sequences-specific processivity factor? Cell 63:655-657[Medline]. |
| 13. |
Cupelli, L., and J. Lenz.
1991.
Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.
J. Virol.
65:6961-6968 |
| 14. |
Derse, D., and J. Casey.
1986.
Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Science
231:1437-1140 |
| 15. |
Hart, C. E.,
J. C. Galphin,
M. A. Westhafer, and G. Schochetman.
1993.
TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12.
J. Virol.
67:5020-5024 |
| 16. |
Hart, C. E.,
C. Y. Ou,
J. C. Galphin,
J. Moore,
L. T. Bacheler,
J. J. Wasmuth,
S. R. J. Petteway, and G. Schochetman.
1989.
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.
Science
246:488-491 |
| 17. |
Hauber, J., and B. R. Cullen.
1988.
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type 1 long terminal repeat.
J. Virol.
62:673-679 |
| 18. |
Hunter, E.,
A. S. Bhown, and J. C. Bennett.
1978.
Amino-terminal amino acid sequence of the major structural polypeptides of avian retroviruses: sequence homology between reticuloendotheliosis virus p30 and p30s of mammalian retroviruses.
Proc. Natl. Acad. Sci. USA
75:2708-2712 |
| 19. |
Inoue, J.,
M. Yoshida, and M. Seiki.
1987.
Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.
Proc. Natl. Acad. Sci. USA
84:3653-3657 |
| 20. |
Jones, K. A.,
P. A. Luciw, and N. Duchange.
1988.
Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.
Genes Dev.
2:1101-1114 |
| 21. |
Kato, H.,
H. Sumimoto,
P. Pognonec,
C. H. Chen,
C. A. Rosen, and R. G. Roeder.
1992.
HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
Genes Dev.
6:655-666 |
| 22. |
Kewelramani, V. N.,
A. T. Panganiban, and M. Emerman.
1992.
Spleen necrosis virus, an avian immunosuppressive retrovirus, shares a receptor with the type D simian retroviruses.
J. Virol.
66:3026-3031 |
| 23. | Kiss-Toth, E., and I. Unk. 1994. A downstream regulatory element activates the bovine leukemia virus promoter. Biochem. Biophys. Res. Commun. 202:1553-1561[Medline]. |
| 24. | Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292[Medline]. |
| 25. |
Laspia, M. F.,
A. P. Rice, and M. B. Mathews.
1990.
Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
Genes Dev.
4:2397-2408 |
| 26. |
Lobel, L. I., and S. P. Goff.
1985.
Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences.
J. Virol.
53:447-455 |
| 27. | Lopez-Lastra, M., C. Gabus, and J. L. Darlix. 1997. Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors. Hum. Gene Ther. 8:1855-1865[Medline]. |
| 28. | Marciniak, R. A., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1990. HIV-1 tat protein trans-activates transcription in vitro. Cell 63:791-802[Medline]. |
| 29. | Marciniak, R. A., and P. A. Sharp. 1991. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:4189-4196[Medline]. |
| 30. | Montagne, J., and P. Jalinot. 1995. Characterization of a transcriptional attenuator within the 5' R region of the human T cell leukemia virus type 1. AIDS Res. Hum. Retroviruses 11:1123-1129[Medline]. |
| 31. | Morrison, H. L., B. Soni, and J. Lenz. 1995. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455[Abstract]. |
| 32. | Newstein, M., I. S. Lee, D. S. Venturini, and P. R. Shank. 1993. A chimeric human immunodeficiency type 1 TAR region which mediates high level trans-activation in both rodent and human cells. Virology 197:825-828[Medline]. |
| 33. |
Newstein, M.,
E. J. Stanbridge,
G. Casey, and P. R. Shank.
1990.
Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells.
J. Virol.
64:4565-4567 |
| 34. | Nieves, A., L. S. Levy, and J. Lenz. 1997. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3. J. Virol. 71:1213-1219[Abstract]. |
| 35. | Ohtani, K., M. Nakamura, S. Saito, T. Noda, Y. Ito, K. Sugamura, and Y. Hinuma. 1987. Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J. 6:389-395[Medline]. |
| 36. |
Oroszlan, S.,
M. Barbacid,
T. D. Copeland,
S. A. Aaronson, and R. V. Gilden.
1981.
Chemical and immunological characterization of the major structural protein (p28) of MMC-1, a rhesus monkey endogenous type C virus: homology with the major structural protein of avian reticuloendotheliosis virus.
J. Virol.
39:845-854 |
| 37. | Pantginis, J., R. M. Beaty, L. S. Levy, and J. Lenz. 1997. The feline leukemia virus long terminal repeat contains a potent determinant of T-cell lymphomagenicity. J. Virol. 71:9786-9791[Abstract]. |
| 38. |
Peters, G. G., and C. Glover.
1980.
Low-molecular-weight RNAs and initiation of RNA-directed DNA synthesis in avian reticuloendotheliosis virus.
J. Virol.
33:708-716 |
| 39. |
Pierce, J.,
B. E. Fee,
M. G. Toohey, and D. O. Peterson.
1993.
A mouse mammary tumor virus promoter element near the transcription initiation site.
J. Virol.
67:415-424 |
| 40. |
Ridgway, A. A. G.,
H.-J. Kung, and D. J. Fujita.
1989.
Transient expression analysis of the reticuloendotheliosis virus long terminal repeat element.
Nucleic Acids Res.
17:3199-3215 |
| 41. | Rosen, C. A., J. Sodroski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823[Medline]. |
| 42. |
Rosen, C. A.,
J. G. Sodroski,
K. Campbell, and W. A. Haseltine.
1986.
Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III transactivator genes.
J. Virol.
57:379-384 |
| 43. | Selby, M. J., and B. M. Peterlin. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776[Medline]. |
| 44. |
Sheldon, M.,
R. Ratnasabapathy, and N. Hernandez.
1993.
Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs.
Mol. Cell. Biol.
13:1251-1263 |
| 45. | Southgate, C., M. L. Zapp, and M. R. Green. 1990. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature 345:640-642[Medline]. |
| 46. |
Speck, N. A.,
B. Renjifo,
E. Golemis,
T. Fredrickson,
J. Hartley, and N. Hopkins.
1990.
Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Genes Dev.
4:233-242 |
| 47. | Sutton, J. A., M. Braddock, A. J. Kingsman, and S. M. Kingsman. 1995. Requirement for HIV-1 TAR sequences for Tat activation in rodent cells. Virology 206:690-694[Medline]. |
| 48. | Tsai, W. P., T. D. Copeland, and S. Oroszlan. 1986. Biosynthesis and chemical and immunological characterization of avian reticuloendotheliosis virus env gene-encoded proteins. Virology 155:567-583[Medline]. |
| 49. | Vogt, V. M. 1997. Retroviral virions and genomes, p. 27-69. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 50. | Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462[Medline]. |
| 51. | Weiss, R., N. Teich, H. Varmus, and J. Coffin. 1982. RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 52. |
Yang, X.,
M. O. Gold,
D. N. Tang,
D. E. Lewis,
E. Aguilar-Cordova,
A. P. Rice, and C. H. Herrmann.
1997.
TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinase and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines.
Proc. Natl. Acad. Sci. USA
94:12331-12336 |
| 53. |
Zaiman, A. L.,
A. Nieves, and J. Lenz.
1998.
CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
J. Virol.
72:3129-3137 |
| 54. |
Zhou, Q., and P. A. Sharp.
1996.
Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.
Science
274:605-610 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|